Records containing: Type 2 Diabetes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-05-12ClinicalTrials.gov study NCT00854503
-
CLINICAL_TRIALS study record update · 2011-05-10ClinicalTrials.gov study NCT00558935
-
CLINICAL_TRIALS study record update · 2011-05-06Effects of 3 Months of Supervised Exercise Training on Cardiometabolic and Inflammatory Biomarkers According to Glucose Tolerance (Normal, Intolerance and Type 2 Diabetes): Measures in Unstimulated and Stimulated Conditions
-
CLINICAL_TRIALS study record update · 2011-05-05A Randomized, Double Blind, Placebo Controlled Study of the Application of Magnetic Fields Using the Resonator in Adjunctive Management of Type 2 Diabetes Mellitus, Pilot Study II
-
CLINICAL_TRIALS study record update · 2011-05-04Taking Action Together: Development, Implementation and Evaluation of Community-Based Programs That Aims to Reduce Risk of Type 2 Diabetes in High BMI African American Children.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-04-29Efficacy of Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy
-
CLINICAL_TRIALS study record update · 2011-04-29Copenhagen Obesity Risk Assessment Study - A Double Blind Randomized Dietary Intervention Study Examining the Effect of a High Intake of Trans Fatty Acids on Abdominal Obesity and Risk Markers of Type 2 Diabetes and Cardiovascular Disease.
-
CLINICAL_TRIALS study record update · 2011-04-26Phase 4 Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
-
CLINICAL_TRIALS study record update · 2011-04-26The Safety, Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese T2DM
-
CLINICAL_TRIALS study record update · 2011-04-22The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients
-
CLINICAL_TRIALS study record update · 2011-04-13White Blood Cells Gene Expression Profiles as a Tool for Predicting Metformin Efficacy in Patients With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2011-04-06The Effects of Caloric Restriction on Fetuin-A and Cardiovascular Risk Factors in Rats and Humans: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2011-01-26A Randomized Trial Comparing Exenatide With Placebo in Subjects With Type 2 Diabetes on Insulin Glargine With or Without Oral Antihyperglycemic Medications
-
CLINICAL_TRIALS study record update · 2011-01-21Mechanism of Action and Efficacy of Saxagliptin (BMS-477118) in the Treatment of Type 2 Diabetic Patients
-
CLINICAL_TRIALS study record update · 2011-01-20A Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8245.
-
CLINICAL_TRIALS study record update · 2010-12-21A Double-blind, Randomized, Parallel, Placebo-controlled 12-week Evaluation of the Safety of Two Doses of TH9507 in Subjects With Stable, Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2010-12-09A Phase III Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of BI 10773 (10 mg, 25 mg) Administered Orally, Once Daily Over 24 Weeks in Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea
-
CLINICAL_TRIALS study record update · 2010-12-07A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction After Single Ascending Oral Doses of AZD6714 in Healthy Male Volunteers and Male Type II Diabetic Patients
-
CLINICAL_TRIALS study record update · 2010-12-06Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients
-
CLINICAL_TRIALS study record update · 2010-12-06Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients
-
CLINICAL_TRIALS study record update · 2010-12-06Gynostemma Pentaphyllum Tea Improves Insulin Sensitivity in Type 2 Diabetic Patients
-
CLINICAL_TRIALS study record update · 2010-12-03A Randomized, Single-Blind, Placebo-Controlled, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Multiple Ascending Oral Doses of AZD1656 in Subjects With T2DM Treated With Insulin
-
CLINICAL_TRIALS study record update · 2010-12-03A Randomized, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Multiple Ascending Oral Doses of AZD1656 in T2DM Subjects
-
CLINICAL_TRIALS study record update · 2010-11-30Effect of Intensive Lifestyle Intervention on Hormonal Factors Regulating Food Intake and Blood Glucose Control in Patients With New Onset Type 2 Diabetes.
-
CLINICAL_TRIALS study record update · 2010-11-30Chronic Reduction of Fasting Gylcaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 Diabetes